semaglutide going away Everyone is talking about what GLP-1 takes away. We think it's time to talk about what it gives you. The clinical data emerging around goes far beyond weight loss and quite Half of Patients Stop Semaglutide

Bioactivation of 6,7-dimethyl-2,4-di-1-pyrrolidinyl-7h-pyrrolo[2,3-d]pyrimidine (U-89843) to reactive intermediates that bind covalently to macromolecules and produce genotoxicity

If you're looking at tablet options because you don't want to inject, the practical question is what your real choices are

CKD patients are often accompanied by gut microbiota dysbiosis, and the use of antibiotics will aggravate the dysbiosis

evidence is limited to in-vitro and animal telomere studies

One study published in 2025 in Diabetologia looked at whether taking GLP-1 drugs were associated with worsening of retinopathy when patients had no or only mild nonproliferative diabetic retinopathy (NPDR) at initiation of treatment